MktsMarkets

Arcadia Biosciences, Inc.
NASDAQ: RKDAKey statistics
RKDA News
Stories mentioning RKDA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,100 | 901.00 | 1,302 | 1,455 | 1,200 | 1,215 | 1,537 | 1,306 |
| Cost of Goods Sold | 700.00 | 708.00 | 884.00 | 824.00 | 682.00 | 827.00 | 1,032 | 633.00 |
| Gross Profit | 400.00 | 193.00 | 418.00 | 631.00 | 518.00 | 388.00 | 505.00 | 673.00 |
| Operating Expenses | ||||||||
| Research & Development | 0.00 | 0.00 | 9.00 | 0.00 | 13.00 | 24.00 | 10.00 | |
| Sales General & Admin | 1,179 | 1,570 | 1,570 | 2,123 | 1,738 | 2,655 | 2,241 | 2,683 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (779.00) | (1,377) | (1,152) | (501.00) | 530.00 | (2,280) | (1,760) | 1,980 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (1,504) | (460.00) | 1,698 | 1,071 | 0.00 | (137.00) | 15.00 | 150.00 |
| Pretax Income | (1,182) | 1,850 | ||||||
| Tax Provision | 0.00 | 0.00 | ||||||
| Net Income (Loss) | (4,385) | (1,336) | 856.00 | (4,458) | 2,599 | (4,064) | (1,612) | 1,061 |
| Earnings Per Share (Basic) | (2.11) | (0.98) | 0.63 | (3.26) | 1.90 | (2.98) | (1.18) | 0.78 |
| Earnings Per Share (Diluted) | (2.11) | (0.98) | 0.62 | (3.26) | 1.90 | (2.98) | (1.18) | 0.78 |
| Weighted Average Shares Outstanding (Basic) | 2,083 | 1,368 | 1,367 | 1,367 | 1,366 | 1,363 | 1,364 | 1,363 |
| Weighted Average Shares Outstanding (Diluted) | 2,083 | 1,368 | 1,372 | 1,367 | 1,366 | 1,363 | 1,364 | 1,363 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About RKDA
Arcadia Biosciences, Inc. (NASDAQ: RKDA) is a stock listed on the Nasdaq Stock Market under the ticker symbol RKDA. It last traded at $0.1600 (Nov 6, 2026, 4:00 PM ET), down 3.5% on the day. That gives Arcadia Biosciences a market capitalisation of $387.9K.
Over the past 52 weeks RKDA has traded between $0.1100 and $4.18.
Revenue for the quarter ended Mar 31, 2026 was $1.1M; a net loss of $4.4M. Revenue was down 8.3% from $1.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.1M | -$4.4M | -398.6% |
| Dec 31, 2025 | $901.0K | -$1.3M | -148.3% |
| Sep 30, 2025 | $1.3M | $856.0K | 65.7% |
| Jun 30, 2025 | $1.5M | -$4.5M | -306.4% |
From Arcadia Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…